Axios: Exclusive – Blueprint inputs Series A for therapy assessment tools
Axios – June 27, 2023
By Erin Brodwin
Blueprint, a developer of patient tracking and outcomes assessment tools for mental health clinicians, raised $9 million in Series A funds, CEO Danny Freed tells Axios exclusively.
Why it matters: While recent allegations of misconduct among telemental health startups have grabbed headlines, the traditional therapy industry lacks technology-based tools to assess the efficacy of its treatments.
How it works: The Chicago-based company offers software on a subscription basis that lets providers manage and track patients and gather large outcomes-based datasets to assess their own efficacy. The software also…
To read the full article, please click here.